Suppr超能文献

[使用卡铂和依托泊苷(VP 16)联合治疗高度恶性、治疗中进展的威尔姆斯瘤实现完全缓解]

[Complete remission of a highly malignant, progressive under therapy Wilm's tumor using the combination carboplatin and etoposide (VP 16)].

作者信息

Walka M M, Schröter W, Lakomek M

机构信息

Universitäts-Kinderklinik Göttingen.

出版信息

Monatsschr Kinderheilkd. 1991 Dec;139(12):836-40.

PMID:1663216
Abstract

A Wilms' tumor in a 4 year old girl did not diminish under preoperative chemotherapy following SIOP 9/GPO study guidelines. Surgery revealed an anaplastic (high grade) nephroblastoma infiltrating pancreas, transverse colon, and diaphragm. During postoperative treatment with ifosfamide, vincristine, actinomycin D, and doxorubicin, there was massive tumor growth per continuitatem in chest and abdomen within 6 weeks. Following a French study for relapsed Wilms' tumor, we gave 160 mg/m2 carboplatin and 100 mg/m2 etoposide on 5 consecutive days. After only one cycle, the tumor showed already remarkable regress. We applied six cycles of carboplatin/etoposide and a abdominal radiation. At the end of therapy, the patient was in complete remission. Side effects of chemotherapy were severe bone marrow aplasia and a moderate and reversible decrease of creatinine clearance. The combination of carboplatin and etoposide is a promising therapy in Wilms' tumor resistant to classic nephroblastoma drugs like vincristine, doxorubicin, and actinomycin D.

摘要

一名4岁女孩的肾母细胞瘤,按照国际小儿肿瘤学会(SIOP)9/GPO研究指南进行术前化疗后并未缩小。手术发现为间变性(高级别)肾母细胞瘤,浸润至胰腺、横结肠和膈肌。在术后使用异环磷酰胺、长春新碱、放线菌素D和阿霉素治疗期间,6周内胸部和腹部出现大量连续性肿瘤生长。参照一项针对复发性肾母细胞瘤的法国研究,我们连续5天给予160mg/m²卡铂和100mg/m²依托泊苷。仅一个周期后,肿瘤就已显示出显著消退。我们应用了六个周期的卡铂/依托泊苷方案并进行了腹部放疗。治疗结束时,患者完全缓解。化疗的副作用为严重的骨髓再生障碍以及肌酐清除率中度且可逆的下降。卡铂和依托泊苷联合应用,对于对长春新碱、阿霉素和放线菌素D等经典肾母细胞瘤药物耐药的肾母细胞瘤是一种有前景的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验